# Yasuo Miyoshi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yasuo-miyoshi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,389 |
| Field | Breast Cancer Treatment Studies |
| h-index | 61 |
| i10-index | 191 |
| Last Known Institution | Hyogo Medical University |
| OpenAlex ID | https://openalex.org/A5071189878 |
| ORCID iD | https://orcid.org/0000-0001-8535-4008 |
| Works | 405 |

## Researcher papers

- [Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis](https://scholariq.org/papers/molecular-features-of-triple-negative-breast-cancer-cells-by-genome-wide-gene/)
- [Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial](https://scholariq.org/papers/trastuzumab-deruxtecan-versus-treatment-of-physician-s-choice-in-patients-with/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Researcher university

- [Hyogo Medical University](https://scholariq.org/institutions/hyogo-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.